VERAXA Biotech partners with OmniAb for Bispecific Antibody Drug
05 May 2025 //
GLOBENEWSWIRE
Swiss biotech Veraxa to list on Nasdaq in $1.64 billion SPAC deal
23 Apr 2025 //
REUTER
Xlife Sciences AG Announces Veraxa Biotech NASDAQ Listing Plans
16 Dec 2024 //
PHARMAWEB
Veraxa and Quadira Enter ADC Development Partnership
15 Jun 2021 //
CONTRACTPHARMA